Selected research
Market Structure
Global Topical Thrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Topical Thrombin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Thrombin include Takeda, Shanghai RAAS, Pfizer, Hualan Biological, Bayer, Omrix Biopharmaceuticals, Octapharma, Haematologic Technologies and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Topical Thrombin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Topical Thrombin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Topical Thrombin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Thrombin market size, projected growth trends, production technologies, key applications, and end-use industries.
Topical Thrombin Segment by Company
Takeda
Shanghai RAAS
Pfizer
Hualan Biological
Bayer
Omrix Biopharmaceuticals
Octapharma
Haematologic Technologies
Grifols
GE Healthcare
CSL
Topical Thrombin Segment by Type
Based Bovine
Based Human
Others
Topical Thrombin Segment by Application
Academic and Research Institute
Hospitals
Diagnostics & Clinics
Topical Thrombin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Thrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Thrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Thrombin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Topical Thrombin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Topical Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Topical Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Based Bovine
- Based Human
- Others
Applications
- Academic and Research Institute
- Hospitals
- Diagnostics & Clinics
Companies covered
- Takeda
- Shanghai RAAS
- Pfizer
- Hualan Biological
- Bayer
- Omrix Biopharmaceuticals
- Octapharma
- Haematologic Technologies
- Grifols
- GE Healthcare
- CSL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Topical Thrombin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Topical Thrombin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Topical Thrombin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Topical Thrombin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Topical Thrombin Market Dynamics
- 2.1 Topical Thrombin Industry Trends
- 2.2 Topical Thrombin Industry Drivers
- 2.3 Topical Thrombin Industry Opportunities and Challenges
- 2.4 Topical Thrombin Industry Restraints
3 Topical Thrombin Market by Manufacturers
- 3.1 Global Topical Thrombin Revenue by Manufacturers (2021-2026)
- 3.2 Global Topical Thrombin Sales by Manufacturers (2021-2026)
- 3.3 Global Topical Thrombin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Topical Thrombin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Thrombin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Topical Thrombin Manufacturers, Product Type & Application
- 3.7 Global Topical Thrombin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Topical Thrombin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Topical Thrombin Players Market Share by Revenue in 2025
- 3.8.3 2025 Topical Thrombin Tier 1, Tier 2, and Tier 3
4 Topical Thrombin Market by Type
- 4.1 Topical Thrombin Type Introduction
- 4.1.1 Based Bovine
- 4.1.2 Based Human
- 4.1.3 Others
- 4.2 Global Topical Thrombin Sales by Type
- 4.2.1 Global Topical Thrombin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Topical Thrombin Sales by Type (2021-2032)
- 4.2.3 Global Topical Thrombin Sales Market Share by Type (2021-2032)
- 4.3 Global Topical Thrombin Revenue by Type
- 4.3.1 Global Topical Thrombin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Topical Thrombin Revenue by Type (2021-2032)
- 4.3.3 Global Topical Thrombin Revenue Market Share by Type (2021-2032)
5 Topical Thrombin Market by Application
- 5.1 Topical Thrombin Application Introduction
- 5.1.1 Academic and Research Institute
- 5.1.2 Hospitals
- 5.1.3 Diagnostics & Clinics
- 5.2 Global Topical Thrombin Sales by Application
- 5.2.1 Global Topical Thrombin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Topical Thrombin Sales by Application (2021-2032)
- 5.2.3 Global Topical Thrombin Sales Market Share by Application (2021-2032)
- 5.3 Global Topical Thrombin Revenue by Application
- 5.3.1 Global Topical Thrombin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Topical Thrombin Revenue by Application (2021-2032)
- 5.3.3 Global Topical Thrombin Revenue Market Share by Application (2021-2032)
6 Global Topical Thrombin Sales by Region
- 6.1 Global Topical Thrombin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Topical Thrombin Sales by Region (2021-2032)
- 6.2.1 Global Topical Thrombin Sales by Region (2021-2026)
- 6.2.2 Global Topical Thrombin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Topical Thrombin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Topical Thrombin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Topical Thrombin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Topical Thrombin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Topical Thrombin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Topical Thrombin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Topical Thrombin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Topical Thrombin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Topical Thrombin Revenue by Region
- 7.1 Global Topical Thrombin Revenue by Region
- 7.1.1 Global Topical Thrombin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Topical Thrombin Revenue by Region (2021-2026)
- 7.1.3 Global Topical Thrombin Revenue by Region (2027-2032)
- 7.1.4 Global Topical Thrombin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Topical Thrombin Revenue (2021-2032)
- 7.2.2 North America Topical Thrombin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Topical Thrombin Revenue (2021-2032)
- 7.3.2 Europe Topical Thrombin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Topical Thrombin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Topical Thrombin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Topical Thrombin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Topical Thrombin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Takeda
- 8.1.1 Takeda Company Information
- 8.1.2 Takeda Business Overview
- 8.1.3 Takeda Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Takeda Topical Thrombin Product Portfolio
- 8.1.5 Takeda Recent Developments
- 8.2 Shanghai RAAS
- 8.2.1 Shanghai RAAS Company Information
- 8.2.2 Shanghai RAAS Business Overview
- 8.2.3 Shanghai RAAS Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shanghai RAAS Topical Thrombin Product Portfolio
- 8.2.5 Shanghai RAAS Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Topical Thrombin Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Hualan Biological
- 8.4.1 Hualan Biological Company Information
- 8.4.2 Hualan Biological Business Overview
- 8.4.3 Hualan Biological Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Hualan Biological Topical Thrombin Product Portfolio
- 8.4.5 Hualan Biological Recent Developments
- 8.5 Bayer
- 8.5.1 Bayer Company Information
- 8.5.2 Bayer Business Overview
- 8.5.3 Bayer Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bayer Topical Thrombin Product Portfolio
- 8.5.5 Bayer Recent Developments
- 8.6 Omrix Biopharmaceuticals
- 8.6.1 Omrix Biopharmaceuticals Company Information
- 8.6.2 Omrix Biopharmaceuticals Business Overview
- 8.6.3 Omrix Biopharmaceuticals Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Omrix Biopharmaceuticals Topical Thrombin Product Portfolio
- 8.6.5 Omrix Biopharmaceuticals Recent Developments
- 8.7 Octapharma
- 8.7.1 Octapharma Company Information
- 8.7.2 Octapharma Business Overview
- 8.7.3 Octapharma Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Octapharma Topical Thrombin Product Portfolio
- 8.7.5 Octapharma Recent Developments
- 8.8 Haematologic Technologies
- 8.8.1 Haematologic Technologies Company Information
- 8.8.2 Haematologic Technologies Business Overview
- 8.8.3 Haematologic Technologies Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Haematologic Technologies Topical Thrombin Product Portfolio
- 8.8.5 Haematologic Technologies Recent Developments
- 8.9 Grifols
- 8.9.1 Grifols Company Information
- 8.9.2 Grifols Business Overview
- 8.9.3 Grifols Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Grifols Topical Thrombin Product Portfolio
- 8.9.5 Grifols Recent Developments
- 8.10 GE Healthcare
- 8.10.1 GE Healthcare Company Information
- 8.10.2 GE Healthcare Business Overview
- 8.10.3 GE Healthcare Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 GE Healthcare Topical Thrombin Product Portfolio
- 8.10.5 GE Healthcare Recent Developments
- 8.11 CSL
- 8.11.1 CSL Company Information
- 8.11.2 CSL Business Overview
- 8.11.3 CSL Topical Thrombin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 CSL Topical Thrombin Product Portfolio
- 8.11.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Topical Thrombin Value Chain Analysis
- 9.1.1 Topical Thrombin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Topical Thrombin Production Mode & Process
- 9.2 Topical Thrombin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Topical Thrombin Distributors
- 9.2.3 Topical Thrombin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst